Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 10, 2008MedicinaOpen Access

Venous thromboembolism and prophylaxis in cancer patients

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does venous thromboembolism prophylaxis prevent venous thromboembolism and improve survival in cancer patients?

Population

Patients with cancer

Design

Review

Authors

SPSaulius PaškauskasJPJuozas PundziusGBGiedrius Barauskas

Discussion

Loading...

Member takes

Overview

High VTE mortality post-cancer surgery supports prophylaxis vigilance; leaves open survival benefits in prospective trials.

Structured PICO

Does venous thromboembolism prophylaxis prevent venous thromboembolism and improve survival in cancer patients?

P
Population
Patients with cancer
I
Intervention
Venous thromboembolism prophylaxis (mechanical, pharmacological, or a combination of both)
O
Outcome
Venous thromboembolism, early lethal outcome, and survival

Venous thromboembolism is a leading cause of mortality in cancer patients, emphasizing the critical importance of guideline-directed thromboprophylaxis.

Cite This Study

Paškauskas et al. (2008) studied this question.

synapsesocial.com/papers/6a76367d74b63c188eb22723https://doi.org/10.3390/medicina44030022
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Venous thromboembolism in cancer patients2013
  2. 2Venous Thromboembolism in Cancer Patients2014 · 8 citations
  3. 3Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis2007 · 41 citations
  4. 4Cancer and Venous Thromboembolism. Clinical Implications of Strong Association2006 · 7 citations
  5. 5Cancer and Venous Thromboembolic Disease: A Review2017 · 254 citations